SCHEMBL9486165

SCHEMBL9486165

O=C(Nc1ccc(F)cc1)NS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.74
CA1 P00915 9/20 0.62
CA2 P00918 9/20 0.62
CA12 O43570 7/20 0.62
CA9 Q16790 7/20 0.62
EGFR P00533 2/20 0.59
ERBB2 P04626 2/20 0.59
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
CA4 P22748 2/20 0.56
CA7 P43166 2/20 0.56
POLB P06746 1/20 0.55
RAB9A P51151 1/20 0.55
FLT1 P17948 1/20 0.55
FLT4 P35916 1/20 0.55
KDR P35968 1/20 0.55
RECQL P46063 1/20 0.55
IDH1 O75874 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9487468 1.00 TP53 (0.74) TP53CA1CA2CA12CA9
SCHEMBL9486495 0.92 CA12 (0.66) TP53CA1CA2CA12CA9
SCHEMBL9486456 0.85 TP53 (1.00) TP53CA1CA2CA12CA9
SCHEMBL5184835 0.85 IDO1 (0.61) TP53CA1CA2CA12CA9
Ly-181984 SCHEMBL4612056 0.85 RECQL (0.74) TP53CA1CA2CA12CA9
SCHEMBL9096201 0.85 ALDH1A1 (0.60) TP53CA1CA2CA12CA9
SCHEMBL5186566 0.84 LMNA (0.72) CA1CA2CA12CA9EGFR
SCHEMBL9529388 0.84 LMNA (0.63) CA1CA2CA12CA9EGFR
SCHEMBL4457678 0.84 TP53 (0.73) TP53CA1CA2CA12CA9
SCHEMBL9488026 0.84 CNR2 (0.61) TP53CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5260338-A Sulfonylureas ELI LILLY AND COMPANY (US) 1993-11-09 US disclosed
EP-0166615-B1 IMPROVEMENTS IN OR RELATING TO BENZENESULFONAMIDO DERIVATIVES ELI LILLY AND COMPANY (US) 1993-05-26 EP disclosed
US-5110830-A Benzenesulfonamides treatment of tumors susceptible to ELI LILLY AND COMPANY (US) 1992-05-05 US disclosed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US disclosed
EP-0166615-A2 Improvements in or relating to benzenesulfonamido derivatives ELI LILLY AND COMPANY (US) 1986-01-02 EP disclosed